The definition of non-responder to multiple sclerosis treatment: neuroimaging markers

Area of Science:

• Neurology
• Radiology
• Clinical Trials

Background:

• Magnetic Resonance Imaging (MRI) is essential for diagnosing multiple sclerosis (MS) and assessing treatment efficacy in clinical trials.
• Weak correlations between clinical symptoms and MRI findings in established MS pose challenges for treatment response evaluation.
• Defining treatment response based solely on MRI metrics remains difficult for individual patients.

Purpose of the Study:

• To highlight the challenges in evaluating MS treatment response using MRI.
• To emphasize the need for integrated clinical and MRI data in patient management.

Main Methods:

• Review of current practices in MS diagnosis and treatment evaluation using MRI.
• Analysis of the limitations of MRI in correlating with clinical status in established MS.
• Discussion of evidence supporting the integration of clinical and MRI data.

Main Results:

• MRI is a primary tool for MS diagnosis and clinical trial assessment.
• Clinical and MRI data show weak correlations in established MS, complicating treatment response definition.
• Recent evidence supports using MRI-derived metrics for individual patient treatment strategies.

Conclusions:

• The integration of clinical and MRI data is essential for reliable patient work-up in MS.
• A combined approach is necessary for effective management of patients undergoing disease-modifying treatments for MS.